{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:44:30Z","timestamp":1792226670446,"version":"4.4.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1053\/j.akdh.2023.11.002","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T03:55:50Z","timestamp":1713671750000},"page":"147-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Liver Disease\u2013Associated Glomerulopathies"],"prefix":"10.1053","volume":"31","author":[{"given":"Swetha R.","family":"Kanduri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3569-1270","authenticated-orcid":false,"given":"Yonatan","family":"Peleg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Wadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1053\/j.akdh.2023.11.002_bib1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1990.32","article-title":"Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations","volume":"37","author":"Johnson","year":"1990","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.akdh.2023.11.002_bib3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2215\/CJN.09180816","article-title":"Viral-associated GN: hepatitis B and other viral infections","volume":"12","author":"Kupin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.11.002_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5414\/CN107615","article-title":"Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy","volume":"78","author":"Li","year":"2012","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000077065","article-title":"Hepatitis B virus-associated nephropathy","volume":"24","author":"Bhimma","year":"2004","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib6","first-page":"380","article-title":"Characterization of 'e' antigen associated with hepatitis B","volume":"35","author":"Tedder","year":"1979","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib7","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1073\/pnas.74.4.1702","article-title":"Host specificity of a serum marker for hepatitis B: evidence that \u201ce antigen\u201c has the properties of an immunoglobulin","volume":"74","author":"Neurath","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1990.32","article-title":"Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations","volume":"37","author":"Johnson","year":"1990","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.akdh.2023.11.002_bib9","first-page":"484","article-title":"Acute immune complex disease associated with hepatitis. Etiopathogenic and immunopathologic studies of the renal lesion","volume":"100","author":"Ozawa","year":"1976","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10157-005-0357-8","article-title":"Mechanisms of immune-deposit formation and the mediation of immune renal injury","volume":"9","author":"Nangaku","year":"2005","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.11.002_bib11","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1046\/j.1523-1755.1999.00407.x","article-title":"Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions","volume":"55","author":"Topham","year":"1999","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib12","first-page":"28","article-title":"Membranous glomerulonephritis associated with hepatitis B antigen in children: a comparison with idiopathic membranous glomerulonephritis","volume":"23","author":"Yoshikawa","year":"1985","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.11.002_bib13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12882-022-02871-y","article-title":"Favorable outcome in PLA2R positive HBV-associated membranous nephropathy","volume":"23","author":"Chen","year":"2022","journal-title":"BMC Nephrol"},{"issue":"4-5","key":"10.1053\/j.akdh.2023.11.002_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000431331","article-title":"Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy","volume":"41","author":"Xie","year":"2015","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib17","first-page":"876","article-title":"Membranous nephropathy associated with viral infection","volume":"14","year":"2020","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ckj\/sfac237","article-title":"The many faces of NELL1 MN","volume":"16","author":"Sethi","year":"2023","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11901-010-0042-6","article-title":"Hepatitis B and renal disease","volume":"9","author":"Chan","year":"2010","journal-title":"Curr Hepat Rep"},{"key":"10.1053\/j.akdh.2023.11.002_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000348478","article-title":"Re-evaluation of the classification system for membranoproliferative glomerulonephritis","volume":"181","author":"Lu","year":"2013","journal-title":"Contrib Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/17474124.2020.1717948","article-title":"Hepatitis B-related glomerulonephritis and optimization of treatment","volume":"14","author":"Liu","year":"2020","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004670050417","article-title":"In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis","volume":"12","author":"He","year":"1998","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-422X-10-300","article-title":"Purified hepatitis B virus induces human mesangial cell proliferation and extracellular matrix expression in Vitro","volume":"10","author":"Diao","year":"2013","journal-title":"Virol J"},{"issue":"21","key":"10.1053\/j.akdh.2023.11.002_bib24","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults","volume":"324","author":"Lai","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10157-008-0124-8","article-title":"Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature","volume":"13","author":"Khaira","year":"2009","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/0886022X.2014.1001711","article-title":"Is there an association of hepatitis B virus infection with minimal change disease of nephrotic syndrome? A clinical observational report","volume":"37","author":"Zhou","year":"2015","journal-title":"Ren Fail"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00467-002-0978-z","article-title":"Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children","volume":"18","author":"Ozdamar","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000185802","article-title":"The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia","volume":"54","author":"Lai","year":"1990","journal-title":"Nephron"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2169\/internalmedicine.53.1203","article-title":"Purpura with ulcerative skin lesions and mixed cryoglobulinemia in a quiescent hepatitis B virus carrier","volume":"53","author":"Yamazaki","year":"2014","journal-title":"Intern Med"},{"issue":"5","key":"10.1053\/j.akdh.2023.11.002_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","article-title":"Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients","volume":"74","author":"Guillevin","year":"1995","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1053\/j.akdh.2023.11.002_bib31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3748\/wjg.v16.i6.770","article-title":"Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis","volume":"16","author":"Zhang","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib32","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/j.1523-1755.2005.00591.x","article-title":"Lamivudine in hepatitis B-associated membranous nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5414\/CN108648","article-title":"Meta-analysis of the efficacy and safety of nucleotide\/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis","volume":"85","author":"Wang","year":"2016","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/0886022X.2013.775659","article-title":"Clinical characteristics and treatment of patients with IgA nephropathy and hepatitis B surface antigen","volume":"35","author":"Sun","year":"2013","journal-title":"Ren Fail"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2468-1253(16)30107-8","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial","volume":"1","author":"Buti","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2468-1253(16)30024-3","article-title":"GS-US-320-0110 Investigators, Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial","volume":"1","author":"Chan","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1345\/aph.1E419","article-title":"Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication","volume":"39","author":"Sayarlioglu","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib39","first-page":"486","article-title":"Efficacy and safety of rituximab in hepatitis B virus-associated PLA2R-positive membranous nephropathy. Kidney Int Rep","volume":"3","author":"Berchtold","year":"2017","journal-title":"Kidney Int"},{"issue":"16","key":"10.1053\/j.akdh.2023.11.002_bib40","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.2013.281115","article-title":"Increased HBV reactivation risk with ofatumumab or rituximab","volume":"310","author":"FDA","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1053\/j.akdh.2023.11.002_bib41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.dld.2016.03.018","article-title":"Hepatitis B virus related cryoglobulinemic vasculitis: a multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC","volume":"48","author":"Mazzaro","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.gtc.2015.07.002","article-title":"Epidemiology of hepatitis C virus: a battle on new frontiers","volume":"44","author":"Shire","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"issue":"12","key":"10.1053\/j.akdh.2023.11.002_bib43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archinte.167.12.1271","article-title":"Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease","volume":"167","author":"Tsui","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2010.01.015","article-title":"Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study","volume":"56","author":"Lee","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2010.09.023","article-title":"HCV infection and the incidence of CKD","volume":"57","author":"Butt","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"14","key":"10.1053\/j.akdh.2023.11.002_bib46","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32830e0152","article-title":"The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis","volume":"22","author":"Wyatt","year":"2008","journal-title":"Aids"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib47","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2215\/CJN.00470107","article-title":"Hepatitis C virus infection and the prevalence of renal insufficiency","volume":"2","author":"Dalrymple","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib48","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1681\/ASN.2005091006","article-title":"Relationship between hepatitis C and chronic kidney disease: results from the third national health and nutrition examination survey","volume":"17","author":"Tsui","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.11.002_bib49","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.ajkd.2008.03.009","article-title":"Association of hepatitis C virus infection with prevalence and development of kidney disease","volume":"51","author":"Moe","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cgh.2009.08.031","article-title":"Lack of association between hepatitis C infection and chronic kidney disease","volume":"8","author":"Asrani","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1053\/j.akdh.2023.11.002_bib51","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ki.2013.455","article-title":"A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease","volume":"85","author":"Chen","year":"2014","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2023.11.002_bib52","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.27664","article-title":"Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans","volume":"61","author":"Molnar","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib53","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.29505","article-title":"Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD","volume":"67","author":"Park","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1053\/j.akdh.2023.11.002_bib54","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1007\/s10620-015-3801-y","article-title":"Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis","volume":"60","author":"Fabrizi","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1053\/j.akdh.2023.11.002_bib55","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.18632\/oncotarget.12896","article-title":"A systematic review and meta-analysis: Does hepatitis C virus infection predispose to the development of chronic kidney disease?","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1053\/j.akdh.2023.11.002_bib56","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jvh.12413","article-title":"A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection","volume":"22","author":"Park","year":"2015","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jmv.24353","article-title":"Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: systematic review and meta-analysis","volume":"88","author":"Fabrizi","year":"2016","journal-title":"J Med Virol"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/sdi.12759","article-title":"The association of hepatitis C infection with the onset of CKD and progression into ESRD","volume":"32","author":"Henson","year":"2019","journal-title":"Semin Dial"},{"issue":"7","key":"10.1053\/j.akdh.2023.11.002_bib59","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib60","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/j.ajkd.2012.08.040","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease","volume":"61","author":"Fabrizi","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"17","key":"10.1053\/j.akdh.2023.11.002_bib61","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2174\/138161208784746824","article-title":"HCV and autoimmunity","volume":"14","author":"Ferri","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"8","key":"10.1053\/j.akdh.2023.11.002_bib62","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.04320416","article-title":"Viral-associated GN: hepatitis C and HIV","volume":"12","author":"Kupin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2023.11.002_bib63","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2169\/internalmedicine.37.836","article-title":"Glomerulonephritis in autopsy cases with hepatitis C virus infection","volume":"37","author":"Arase","year":"1998","journal-title":"Intern Med"},{"issue":"10","key":"10.1053\/j.akdh.2023.11.002_bib64","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-144-10-200605160-00007","article-title":"Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation","volume":"144","author":"McGuire","year":"2006","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib65","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ajcp\/aqaa238","article-title":"Spectrum of kidney diseases in patients with hepatitis C virus infection","volume":"156","author":"Guo","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1053\/j.akdh.2023.11.002_bib66","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.2009.247","article-title":"Hepatitis C virus-induced cryoglobulinemia","volume":"76","author":"Charles","year":"2009","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/kel174","article-title":"B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection","volume":"46","author":"Fabris","year":"2007","journal-title":"Rheumatology"},{"issue":"7","key":"10.1053\/j.akdh.2023.11.002_bib68","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/ndt\/gfm205","article-title":"Hepatitis C virus: from entry to renal injury--facts and potentials","volume":"22","author":"Barsoum","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2006.09.015","article-title":"Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis","volume":"49","author":"Roccatello","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib70","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","article-title":"Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis","volume":"54","author":"D'Amico","year":"1998","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib71","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2249.2005.02778.x","article-title":"Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection","volume":"140","author":"Sansonno","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1053\/j.akdh.2023.11.002_bib72","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.1840360621","article-title":"Extrahepatic manifestations of hepatitis C among United States male veterans","volume":"36","author":"El-Serag","year":"2002","journal-title":"Hepatology"},{"issue":"12","key":"10.1053\/j.akdh.2023.11.002_bib73","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1681\/ASN.V9122244","article-title":"Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"9","author":"Markowitz","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific Immunohistochemical marker for fibrillary glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib75","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ki.1989.84","article-title":"Renal involvement in essential mixed cryoglobulinemia","volume":"35","author":"D'Amico","year":"1989","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2023.11.002_bib76","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"3s","key":"10.1053\/j.akdh.2023.11.002_bib77","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","year":"2021","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2023.11.002_bib78","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/j.ajkd.2008.08.005","article-title":"KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD","volume":"52","author":"Gordon","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib79","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cgh.2016.09.158","article-title":"Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals","volume":"15","author":"Bonacci","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1053\/j.akdh.2023.11.002_bib80","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2215\/CJN.02510317","article-title":"Effect of Sofosbuvir-based hepatitis C virus therapy on kidney function in patients with CKD","volume":"12","author":"Sise","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.11.002_bib81","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/hep.28753","article-title":"Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia","volume":"64","author":"Gragnani","year":"2016","journal-title":"Hepatology"},{"issue":"10","key":"10.1053\/j.akdh.2023.11.002_bib82","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/annrheumdis-2015-208339","article-title":"Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study","volume":"75","author":"Saadoun","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib83","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","article-title":"Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents","volume":"63","author":"Sise","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"10.1053\/j.akdh.2023.11.002_bib84","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/liv.13465","article-title":"Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: from interferon-based to direct-acting antivirals era","volume":"37","author":"Cacoub","year":"2017","journal-title":"Liver Int"},{"issue":"8","key":"10.1053\/j.akdh.2023.11.002_bib85","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ajg.2017.49","article-title":"Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia","volume":"112","author":"Emery","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib86","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13075-017-1280-6","article-title":"Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience","volume":"19","author":"Lauletta","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.gastro.2017.03.006","article-title":"Efficacy and safety of Sofosbuvir plus Daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis","volume":"153","author":"Saadoun","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.kint.2019.04.030","article-title":"Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease","volume":"97","author":"Sise","year":"2020","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.akdh.2023.11.002_bib89","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hep4.1528","article-title":"Low complement C4 Predicts improvement of kidney function after direct-acting antiviral therapy for hepatitis C virus","volume":"4","author":"Sise","year":"2020","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib90","first-page":"91","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group, KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"8","year":"2011","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000493807","article-title":"Incidence and characteristics of de novo renal cryoglobulinemia after direct-acting antivirals treatment in an Egyptian hepatitis C cohort","volume":"140","author":"Fayed","year":"2018","journal-title":"Nephron"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib92","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ekir.2018.03.016","article-title":"Persistent hepatitis C virus-associated cryoglobulinemic glomerulonephritis in patients successfully treated with direct-acting antiviral therapy","volume":"3","author":"Santoriello","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib93","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib94","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.34322","article-title":"A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis","volume":"64","author":"Sneller","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib95","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000445841","article-title":"Improved (4 plus 2) rituximab Protocol for severe cases of mixed cryoglobulinemia: a 6-year observational study","volume":"43","author":"Roccatello","year":"2016","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib96","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10067-022-06391-w","article-title":"Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian study group of cryoglobulinemia (GISC)","volume":"42","author":"Quartuccio","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1053\/j.akdh.2023.11.002_bib97","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/jcm12072726","article-title":"Secondary IgA nephropathy and IgA-associated nephropathy: a systematic review of case reports","volume":"12","author":"Tota","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib98","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.kint.2018.02.030","article-title":"Secondary IgA nephropathy","volume":"94","author":"Saha","year":"2018","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib99","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2012.04.028","article-title":"Prospective assessment of renal histopathological lesions in patients with end-stage liver disease: effects on long-term renal function after liver transplantation","volume":"57","author":"Calmus","year":"2012","journal-title":"J Hepatol"},{"issue":"10","key":"10.1053\/j.akdh.2023.11.002_bib100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-144-10-200605160-00007","article-title":"Brief communication:glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation","volume":"144","author":"McGuire","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib101","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2249.2009.04004.x","article-title":"Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation","volume":"158","author":"Massonnet","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib102","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0092-8674(80)90371-2","article-title":"Galactose and N-acetylgalactosamine-specific endocytosis of glycopeptides by isolated rat hepatocytes","volume":"22","author":"Baenziger","year":"1980","journal-title":"Cell"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib103","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0016-5085(88)90252-1","article-title":"Receptor-mediated binding and uptake of immunoglobulin A by human liver","volume":"94","author":"Tomana","year":"1988","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1053\/j.akdh.2023.11.002_bib104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00430547","article-title":"Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part","volume":"392","author":"Nakamoto","year":"1981","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"4","key":"10.1053\/j.akdh.2023.11.002_bib105","first-page":"422","article-title":"Association of overt glomerulonephritis and liver disease: a study of 34 patients","volume":"6","author":"Nochy","year":"1976","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.11.002_bib106","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000184477","article-title":"IgA nephropathy associated with hepatitis B virus antigenemia","volume":"47","author":"Lai","year":"1987","journal-title":"Nephron"},{"issue":"3","key":"10.1053\/j.akdh.2023.11.002_bib107","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.kint.2017.10.019","article-title":"IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis","volume":"93","author":"Suzuki","year":"2018","journal-title":"Kidney Int"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923001209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923001209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T05:31:30Z","timestamp":1713677490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813923001209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2949813923001209"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2023.11.002","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Disease\u2013Associated Glomerulopathies","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2023.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}